Clinical Trial: Development of a Novel Transdiagnostic Intervention for Anhedonia
Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional
Official Title: Development of a Novel Transdiagnostic Intervention for Anhedonia
Brief Summary: The overall goal of this project is to develop a novel transdiagnostic treatment for anhedonia, called Behavioral Activation Treatment for Anhedonia (BATA), using ultra-high field functional neuroimaging. There is a critical need for a validated treatment that specifically targets anhedonia, and this project will evaluate the effects of this new treatment on anhedonia and will establish how this treatment impacts brain systems that mediate reward processing, clinical symptoms of anhedonia, functional outcomes, and behavioral indices of reward processing. This work will also identify brain targets by which future novel anhedonia treatment may be evaluated.
Detailed Summary:
Sponsor: University of North Carolina, Chapel Hill
Current Primary Outcome: Change from Baseline to Week 15 in Neural Activation [ Time Frame: Baseline, 15 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Change from Baseline to Week 15 in Snaith-Hamilton Pleasure Scale Score [ Time Frame: Baseline, 15 weeks ]
Original Secondary Outcome: Same as current
Information By: University of North Carolina, Chapel Hill
Dates:
Date Received: August 17, 2016
Date Started: December 2016
Date Completion: November 2021
Last Updated: August 17, 2016
Last Verified: August 2016